Background: The COVID-19 disease is responsible for a systemic inflammatory activation which may affect the overall cardiovascular system. Aim of the study: investigate the occurrence of right ventricular dysfunction among Pneumonic COVID 19 and non COVID19 patients via echocardiography. Methods: This study is a prospective study that was conducted on 200 patients, divided into two groups: Group one: patients with COVID 19 pneumonia in ICU (n=100). Group two: patients with Non COVID 19 pneumonia in ICU (n=100). Results: Regarding ECG changes ST deviation was higher in covid group (17 patients) as compared with non covid group (7 patients) with p-value (0.02957). Regarding ECG changes AF was higher in covid group (11 patients) as compared with non covid group (one patient) with p-value (0.0193) Regarding Right ventricular failure significantly higher in in COVID group compared to Non-COVID group as 21 patients (21%) belong to COVID group and 7 patients (7%) belong to Non-COVID group with p-value (p=0.00433). Conclusion: The occurrence of right ventricular dysfunction or failure in COVID is higher than non COVID.